Showing 1 - 3 results of 3 for search 'Rishav Adhikari', query time: 0.02s
Refine Results
-
1
National Trends in Use of Sodium‐Glucose Cotransporter‐2 Inhibitors and Glucagon‐like Peptide‐1 Receptor Agonists by Cardiologists and Other Specialties, 2015 to 2020 by Rishav Adhikari, Kunal Jha, Zeina Dardari, James Heyward, Roger S. Blumenthal, Robert H. Eckel, G. Caleb Alexander, Michael J. Blaha
Published 2022-05-01
Article -
2
USE OF SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS BY CARDIOLOGISTS SINCE THE RELEASE OF 2022 AHA/ACC/HFSA GUIDELINES FOR THE MANAGEMENT OF HEART FAILURE by Gowtham R. Grandhi, MD MPH, Rishav Adhikari, MD, Erfan Tasdighi, MD, Albert D. Osei, MD MPH, Michael Khorsandi, MD, Anurag Mehta, MD, Michael Blaha, MD MPH
Published 2023-09-01
Article -
3
Online searches for hepatocellular carcinoma drugs mirror prescription trends across specialties and changes in guideline recommendations by Philipp Berning, Adrian E. Schroer, Rishav Adhikari, Alexander C. Razavi, Francois H. Cornelis, Joseph P. Erinjeri, Stephen B. Solomon, Debkumar Sarkar, Hebert Alberto Vargas, Heiko Schöder, Josef J. Fox, Omar Dzaye, Omar Dzaye
Published 2024-02-01
Article